₹80.50
+₹1.47 (+1.86%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹106 Cr
P/E
51.60
ROE
2.17%
ROCE
5.12%
About Concord Drugs Ltd
Concord Drugs is to manufacture licensed drugs based on the formulations approved.
Founded
1995
CEO
S Nagi Reddy
Employees
250
HQ
Ranga Reddy, Telangana
About Concord Drugs Ltd
Concord Drugs is to manufacture licensed drugs based on the formulations approved.
Founded:1995
CEO:S Nagi Reddy
Employees:250
HQ:Ranga Reddy, Telangana
Finished Products
1Sales
₹80.19CrRaw Materials
1Raw Material
₹33.71Cr2Cost of Material Consumed
₹28.22CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹93
52W Low
₹56
Volume7.79K
Avg VolumeN/A
Beta0.39
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
51.60x
Valuation
P/B Ratio
2.19x
Valuation
EPS
₹1.56
Valuation
Dividend Yield
0.00%
Valuation
ROE
2.17%
Profitability
ROCE
5.12%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacture of Pharmaceutical FormuRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.28x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-4.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.